Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105709826B reveals recyclable manganese catalyst for asymmetric sulfide oxidation, offering cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN116283759B reveals high-yield quinoline synthesis. Enables cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN112745256B reveals a novel non-Pd/C reduction route for Ropinirole intermediates. Achieve high purity and significant cost reduction in API manufacturing.
Patent CN113248422A details a visible-light catalyzed method for chiral azaarenes, offering green synthesis and high enantioselectivity for pharmaceutical intermediates.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high enantioselectivity and potent anticancer activity.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Novel photocatalytic route for dihydronaphthalene derivatives offering mild conditions and high yields for pharmaceutical intermediates.
Patent CN111892528A details a regioselective Ru-catalyzed C-H amidation method, offering cost-effective routes for high-purity pharmaceutical intermediates and scalable API manufacturing.
Patent CN120247882B reveals mild synthesis for antitumor compounds. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel boric porphyrin catalyzed route for avanafil offers high purity and green manufacturing advantages for reliable API intermediate suppliers.
Novel one-step synthesis for spiro pyrrole-indolone derivatives. Enhances stereochemical control and scalability for reliable pharmaceutical intermediates supply chains.
Patent CN116082217B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high cytotoxic activity, offering cost-effective routes for API manufacturing.
Patent CN115260192B reveals a metal-free NHC catalytic route for nitrogen-containing fused rings, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN112898202A details a mild visible-light photocatalytic method for synthesizing heterocyclyl cyclopropane compounds, offering significant advantages for pharmaceutical intermediate manufacturing.
Novel axial chiral bisindole catalyst synthesis offers high enantioselectivity and mild conditions for cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain.
Novel thiourea catalyzed route offers high stereoselectivity and metal-free production for pharmaceutical intermediates ensuring supply chain reliability.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones using chiral phosphoric acid, offering cost-effective solutions for API manufacturing.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN113980028A reveals a mild organocatalytic route for chiral spiro indolones. Discover cost-effective manufacturing and high stereoselectivity for API intermediates.
Novel patent CN116655616B reveals efficient synthesis for chiral ligands enabling cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing processes.